Time Finance Q&A: Revenue improving month on month (LON:TIME)
16 December 2020
FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
Lloyds Banking Group plc (LON: LLOY) has today provided an update on charges relating to the mis-selling of Payment Protection Insurance (‘PPI’). At our half year results on 31 July..
Berkeley Group Holdings PLC (LON:BKG) is holding its Annual General Meeting today, at which it will provide the following Trading Update which covers the period from 1 May 2019 to..
Hiscox Ltd (LON:HSX), today announced the appointment of Joanne Musselle as its new Group Chief Underwriting Officer, after concluding a thorough internal and external search. Joanne is currently Chief Underwriting..
Melrose Industries PLC (LON:MRO) today announced its interim results for the six months ended 30 June 2019. Highlights Adjusted1 results Statutory results Continuing operations 2019 2018 2019 2018 £m..
Barratt Developments Plc (LON:BDEV) today announced its annual results for the year ended 30 June 2019. £m unless otherwise stated1,2,3 Year ended 30 June 2019 Year ended 30 June 2018..
Royal Bank of Scotland Group plc (LON:RBS) today provided an update in respect of charges related to Payment Protection Insurance (“PPI”). RBS has been implementing the FCA’s policy statement for..
AstraZeneca plc (LON:AZN) today announced that it has received marketing authorisation from China’s National Medical Products Administration for Tagrisso as a 1st-line treatment for adults with locally-advanced or metastatic non-small..
Proposed demerger of Wolseley UK The Board of Ferguson plc (LON: FERG) today announced its intention to demerge its UK operations subject to shareholder approval. The decision marks the conclusion..
DS Smith Plc (LON: SMDS), today issued a trading update in respect of the period since 1 May 2019. DS Smith will hold its Annual General Meeting at 12 noon..
Tesco Personal Finance Plc. / Tesco Bank (LON: TSCO) today confirmed the sale of its mortgage portfolio to Lloyds Banking Group (LON: LLOY) for a cash consideration of c. £3.8bn...
Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial. Additionally, Brilinta showed a more favourable clinical benefit in..
AstraZeneca plc (LON:AZN) today announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga on top of standard of care reduced both the incidence of cardiovascular death..
Pursuant to Listing Rule 9.6.14(2) Micro Focus International (LON:MCRO) today announced that Kevin Loosemore, Executive Chairman, has been appointed to the Board of De La Rue plc as a non-executive..
AstraZeneca plc (LON: AZN) today announced that the Phase III TULIP 2 trial for anifrolumab, a potential new medicine for the treatment of systemic lupus erythematosus (SLE), met its primary..
Vodafone Group plc (LON: VOD) will be the Official Communication Partner of Porsche Motorsport when the automobile manufacturer enters the 2019/2020 ABB FIA Formula E Championship. Formula E is the..
AstraZeneca plc (LON:AZN) today announced positive results from the Phase III ETHOS trial for triple-combination therapy Breztri Aerosphere, formerly PT010, in patients with moderate to very severe chronic obstructive pulmonary..
Anglo American plc (LON:AAL) today announced the value of rough diamond sales (Global Sightholder Sales and Auction Sales) for De Beers’ seventh sales cycle of 2019, amounting to $280 million...
AstraZeneca plc (LON:AZN) today announced that the US Food and Drug Administration has granted Orphan Drug Designation to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE). EoE is a..
Bunzl plc (LON:BNZL), the specialist international distribution and services Group, today publishes its half yearly financial report for the six months ended 30 June 2019. Financial results As reported under..
GlaxoSmithKline plc (LON/NYSE: GSK) today announced positive headline results from the pivotal DREAMM-2 open-label, randomised study of two doses of belantamab mafodotin (GSK2857916). The 196 patients in the trial had..
